From the Press
Clexio and Genetika+ Announce Partnership Using Proprietary Antidepressant Screening Platform
Clexio and Genetika+ are partnering to screen and characterise Clexio's antidepressant pipeline using Genetika+'s iPSC-derived neurons platform, allowing for the first time an assessment of the functional effects of drugs directly on human neurons with biologically-relevant biomarkers that have been demonstrated to correlate with clinical response, and enabling the advancement of personalized medicine for psychiatry.
Science seeks new ways to tackle depression: early detection of risks and personalized treatment
The EU-funded project WARN-D aims to predict who is at risk of depression and then develop a customised programme to prevent them from falling into it; the project's ultimate goal is to create an early warning system, which involves a smartphone application to monitor users’ mental health in real-time and detect when an individual is at risk of depression. By identifying people who are at risk of depression, the project hopes to help them stay mentally healthy for longer.
Dr. Daphna Laifenfeld Speaks at PMWC 2022
Genetika+ personalizes treatment in the mental health space, initially focusing on depression. The Genetika+ platform uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.
Female Led Genetika+ Grew and Gained Funding Through MassChallenge
How did a female-led startup from the MC18 Israel cohort turn their MassChallenge experience into a $10 million Series A funding round? Learn more about Genetika+ and its co-founders, Talia Cohen Solal and Daphna Laifenfeld, in our most recent case study.
Genetika+ CEO Talia Cohen Solal Brings Precision Medicine to Brain Health
Depression, historically, has been treated by trial and error until a therapy with a positive and stable outcome can be identified. Genetika+ is changing that with precision, personalized testing that enables the right antidepressant to be selected for patients the first time.